Rash of Generic Price Hikes Pushes UK Health Dept Into Action
Huge hikes in the prices of some generic medicines in the past year have forced the UK health authorities to offer many more “concessionary prices” to pharmacists to ensure continuity of supply and to seek alternative sources of some products. Legislation is due to take effect shortly that will give the government more powers to control generic prices.
You may also be interested in...
Ongoing Investigations into drug price increases could be at risk following a tribunal ruling in the UK phenytoin sodium case, according to the Competition and Markets Authority, which is considering an appeal against the judgment.
Newly passed UK legislation gives the government powers to curb pricing of unbranded generics when market forces fail. The Association of the British Pharmaceutical Industry has welcomed amendments to draft legislation that have addressed its concerns over onerous requirements.
New advice on the use of "mix-and-match" primary and booster vaccine regimens has been published by the EMA and the ECDC, while a new CEPI-supported clinical trial will test heterologous booster combinations involving Medigen’s COVID-19 vaccine and other jabs.